Figure 1.
Cohort creation diagram. ∗The exclusion criteria were residence outside of Iceland at the index date, prior use of oral anticoagulants within 12 months of the index date, prescription of 2.5 mg of rivaroxaban at the index date, and diagnosis of end-stage renal disease, a mechanical heart valve, or mitral stenosis from the index date or earlier.